Josep Jové

Josep Jové

Auto-generated profile, based on publicly available information

Josep Jové

Department of Radiation Oncology, Hospital Germans Trias i Pujol, Carretera de Canyet, s/n, 08916, Badalona, Spain

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Journal of Thoracic Oncology
Verified
Journal Article
Open access
PDF file
MSMarta Simó
Marta Simó
JRJames C. Root
James C. Root
LVLucía Vaquero
Lucía Vaquero
PRPablo Ripollés
Pablo Ripollés
JJJosep Jové
Josep Jové
Antoni Rodriguez-FornellsAntoni Rodriguez-Fornells
Antoni Rodriguez-Fornells
Introduction No study has examined structural brain changes specifically associated with chemotherapy in a lung cancer population. The aim of this cross-sectional study was to assess differences in brain structure between small-cell lung cancer patients (C+) following chemotherapy, non–small-cell lung cancer patients (C−) before chemotherapy and healthy controls (HC). Methods Twenty-eight small-cell lung cancer patients underwent a neuropsychological assessment and a structural magnetic resonance imaging, including T1-weighted and diffusion tensor imaging to examine gray matter density and white matter (WM) integrity, respectively, 1 month following completion of platinum-based chemotherapy. This group was compared with 20 age and education-matched non–small-cell lung cancer patients before receiving chemotherapy and 20 HC. Results Both C+ and C− groups exhibited cognitive impairment compared with the HC group. The C+ group performed significantly worse than HC in verbal fluency and visuospatial subtests; C− performed significantly worse than both C+ and HC in verbal memory. Voxel-based morphometry analysis revealed lower gray matter density in the insula and parahippocampal gyrus bilaterally, and left anterior cingulate cortex in C+ compared with HC. Diffusion tensor imaging indices showed focal decreased WM integrity in left cingulum and bilateral inferior longitudinal fasciculus in the C+ group and more widespread decreased integrity in the C− group compared with the HC group. Conclusion This study demonstrates that lung cancer patients exhibit cognitive impairment before and after chemotherapy. Before the treatment, C− showed verbal memory deficits as well as a widespread WM damage. Following treatment, the C+ group performed exhibited lower visuospatial and verbal fluency abilities, together with structural gray matter and WM differences in bilateral regions integrating the paralimbic system.

1 April 2016 in Journal of Thoracic Oncology
Verified
Journal Article
Closed access
MSMarta Simó
Marta Simó
LVLucía Vaquero
Lucía Vaquero
PRPablo Ripollés
Pablo Ripollés
AGAne Gurtubay-Antolin
Ane Gurtubay-Antolin
JJJosep Jové
Josep Jové
Antoni Rodriguez-FornellsAntoni Rodriguez-Fornells
Antoni Rodriguez-Fornells

2 March 2011 in Radiation Oncology
Verified
Journal Article
Open access
PDF file
SFSalvador Villà Freixa
Salvador Villà Freixa
DWDamien Charles Weber
Damien Charles Weber
CMCristina Moretones
Cristina Moretones
AMAnabel Mañes
Anabel Mañes
CCChristophe Combescure
Christophe Combescure
Francesc GrausFrancesc Graus
Francesc Graus
Background: Prognostic indexes are useful to guide tailored treatment strategies for cancer patients with brain metastasis (BM). We evaluated the new Graded Prognostic Assessment (GPA) scale in a prospective validation study to compare it with two published prognostic indexes. Methods: A total of 285 newly diagnosed BM (n = 85 with synchronous BM) patients, accrued prospectively between 2000 and 2009, were included in this analysis. Mean age was 62 ± 12.0 years. The median KPS and number of BM was 70 (range, 20-100) and 3 (range, 1-50), respectively. The majority of primary tumours were lung (53%), or breast (17%) cancers. Treatment was administered to 255 (89.5%) patients. Only a minority of patients could be classified prospectively in a favourable prognostic class: GPA 3.5-4: 3.9%; recursive partitioning analysis (RPA) 1, 8.4% and Basic Score for BM (BSBM) 3, 9.1%. Mean follow-up (FU) time was 5.2 ± 4.7 months. Results: During the period of FU, 225 (78.9%) patients died. The 6 months- and 1 year-OS was 36.9% and 17.6%, respectively. On multivariate analysis, performance status (P < 0.001), BSBM (P < 0.001), Center (P = 0.007), RPA (P = 0.02) and GPA (P = 0.03) were statistically significant for OS. The survival prediction performances' of all indexes were identical. Noteworthy, the significant OS difference observed within 3 months of diagnosis between the BSBM, RPA and GPA classes/groups was not observed after this cut-off time point. Harrell's concordance indexes C were 0.58, 0.61 and 0.58 for the GPA, BSBM and RPA, respectively. Conclusions: Our data suggest that the new GPA index is a valid prognostic index. In this prospective study, the prediction performance was as good as the BSBM or RPA systems. These published indexes may however have limited long term prognostication capability.

13 March 2017 in Brain Imaging and Behavior
Verified
Journal Article
Closed access
PDF file
MSM. Simó
M. Simó
XRX. Rifà-Ros
X. Rifà-Ros
LVL. Vaquero
L. Vaquero
PRP. Ripollés
P. Ripollés
NCN. Cayuela
N. Cayuela
Antoni Rodriguez-FornellsAntoni Rodriguez-Fornells
Antoni Rodriguez-Fornells

27 May 2015 in Brain Imaging and Behavior
Verified
Journal Article
Closed access
PDF file
MSMarta Simó
Marta Simó
LVLucía Vaquero
Lucía Vaquero
PRPablo Ripollés
Pablo Ripollés
JJJosep Jové
Josep Jové
RFRafael Fuentes
Rafael Fuentes
JBJordi Bruna
Jordi Bruna